Emily Botto | Research Analyst
Tufts Center for the Study of Drug Development

Emily Botto, Research Analyst, Tufts Center for the Study of Drug Development

Emily Botto joined the Tufts Center for the Study of Drug Development (Tufts CSDD) as a Research Analyst in October 2020 after graduating from Brandeis University. Her work focuses on studies relating to clinical research execution strategies and practices as well as clinical trial diversity and inclusion. In her time at Tufts CSDD, she has been published in Applied Clinical Trials for her research on the effect of remote and decentralized clinical trials on global monitoring regulations and practices, as well as in Therapeutic Innovation & Regulatory Science and Clinical Researcher for her work in participant and staff diversity. She is currently earning her master’s in public health at Tufts University.

Appearances:



Festival of Biologics Day 2 @ 17:20

New solutions to leverage the predictive relationship between investigative site personnel diversity and patient enrolment diversity

last published: 31/Jan/23 09:55 GMT
last published: 31/Jan/23 09:55 GMT

back to speakers